Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Irish Residential Properties REIT Aktie 24169369 / IE00BJ34P519

19.08.2026 18:00:06

Dividend Declaration

Irish Residential Properties REIT plc (IRES)
Dividend Declaration

19-Aug-2026 / 17:00 GMT/BST


 

 

19 August 2026

Irish Residential Properties REIT plc

Dividend Declaration

Irish Residential Properties REIT plc (the "Company") announces that, further to the publication of its Interim results for the period from 1 January 2026 to 30 June 2026, the Board of the Company has declared a dividend of 2.5 cent per share for the period ended 30 June 2026. The 2.5 cent per share will be wholly a Property Income Distribution (“PID”) as defined by the Irish REIT legislation and will be paid on 18 September 2026 to shareholders on record on 28 August 2026.

END

For further information please contact:

 

Investor Relations:

Orla Keegan, Head of Investor Relations   Tel: +353 (0) 87 299 2445

Email: investors@iresreit.ie     

 

Media enquiries:

Cathal Barry, Drury                                                                                         Tel: +353 (0) 87 227 9281

Gavin McLoughlin, Drury                                                                             Tel: +353 (0) 86 035 3749

Email: iresreit@drury.ie

 

About Irish Residential Properties REIT plc

Irish Residential Properties REIT plc (“IRES”) is a Real Estate Investment Trust providing quality professionally managed homes in sustainable communities in Ireland. IRES aims to be the provider of choice for the Irish living sector, known for excellent service and for operating responsibly, minimising its environmental impact, and maximising its contribution to the community. The Company's shares are listed on Euronext Dublin. Further information at www.iresreit.ie.

This note applies if and to the extent that there are forward-looking statements in this Announcement.

This Announcement may contain forward-looking statements, which are subject to risks and uncertainties because they relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company or the industry in which it operates, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. The forward-looking statements referred to in this paragraph speak only as at the date of this Announcement. Except as required by law or by any appropriate regulatory authority, the Company will not undertake any obligation to release publicly any revision or updates to these forward-looking statements to reflect future events, circumstances, unanticipated events, new information or otherwise.

 

 



Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

View original content: EQS News
ISIN: IE00BJ34P519
Category Code: DIV
TIDM: IRES
LEI Code: 635400EOPACLULRENY18
Sequence No.: 440433
EQS News ID: 2385920

 
End of Announcement EQS News Service

In eigener Sache

Trading Signals: DocMorris: Turnaround gewinnt an Tempo

Überraschend starke Geschäftszahlen sorgen bei der Aktie von DocMorris wieder für Schwung. Vor allem das kräftige Wachstum im Rezeptgeschäft und die verbesserte Profitabilität machen Hoffnung auf einen nachhaltigen Turnaround - und damit auch auf höhere Kurse.

Weiterlesen!

Analysen zu Irish Residential Properties REIT PLC

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Wabtec, Eli Lilly und Novartis neu im BX Musterportfolio

Im BX Morningcall werden folgende Aktien analysiert und erklärt
✅ Wabtec
✅ Eli Lilly
✅ Novartis

https://bxplus.ch/bx-musterportfolio/

Wabtec, Eli Lilly und Novartis neu im BX Musterportfolio

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 15’190.89 19.37 S3CBQU
Short 15’477.42 13.97 SIBJOU
Short 16’061.65 8.94 S5B0BU
SMI-Kurs: 14’554.31 26.08.2026 17:30:00
Long 13’995.24 19.76 SPBMIU
Long 13’681.71 13.90 SMB1YU
Long 13’076.90 8.83 S5BOUU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com